folic acid
PolandDrugs containing this active substance
-
The medicine is used for the prevention and treatment of folic acid deficiency. It is indicated, among other things, in chronic blood diseases (such as thalassemia or malaria), megaloblastic anemia, chronic malnutrition, alcoholism, and in individuals taking certain medications or using oral contraceptives.
Form: tablets
Active substance Dosage folic acid 5 mg ATC: B03BB01
Manufacturer: Gedeon Richter Polska Sp. z o.o.
-
The medicine is used for the prevention and treatment of folic acid deficiency. It is indicated, among other things, in chronic blood diseases (such as thalassemia or malaria), megaloblastic anemia, chronic malnutrition, alcoholism, and in individuals using oral contraceptives or undergoing dialysis.
Form: tablets
Active substance Dosage folic acid 15 mg ATC: B03BB01
Manufacturer: Grodzisk Pharmaceutical Works "Polfa" Sp. z o.o.
-
The medicinal product is used to reduce the harmful effects and to treat an overdose of certain anticancer drugs (e.g., methotrexate) and for the treatment of cancer in combination with fluorouracil.
Form: solution for injection for infusion
Active substance Dosage folic acid 10 mg/ml ATC: V03AF03
Manufacturer: AS Kalceks
-
The medicine is used in adults and children to reduce the side effects of certain anticancer drugs or in cases of overdose. It helps to neutralize the toxic effects of drugs from the folic acid antagonist group (e.g., methotrexate, trimethoprim, or pyrimethamine).
Form: solution for injection and infusion
Active substance Dosage folic acid 10 mg/ml ATC: V03AF03
Manufacturer: Ebewe Pharma Ges.m.b.H Nfg. KG
-
The medicinal product is used to provide vitamins to patients who are being fed intravenously (via drip).
Form: powder for preparation of solution for injection and infusion
Active substance Dosage retinyl palmitate 3500 j.m. cholecalciferol 220 j.m. dl-alpha-tocopherol 10.2 mg ascorbic acid 125 mg cocarboxylase tetrahydricum 5.8 mg sodium riboflavin phosphate 5.67 mg pyridoxine hydrochloride 5.5 mg cyanocobalamin 6 mcg folic acid 414 mcg dexpanthenol 16.15 mg biotinum 69 mcg nicotinamide 46 mg ATC: B05XC
Manufacturer: Baxter S.A.
-
It is used for the prevention and treatment of conditions caused by folic acid deficiency, such as megaloblastic anemia. It is also recommended for women planning pregnancy who have previously given birth to a child with a neural tube defect.
Form: tablets
Active substance Dosage folic acid 5 mg ATC: B03BB01
Manufacturer: Pharmaceutical and Chemical Enterprise "Synteza" Sp. z o.o.
-
It is used in the treatment of megaloblastic anemia.
Form: tablets
Active substance Dosage folic acid 15 mg ATC: B03BB01
Manufacturer: Pharmaceutical and Chemical Enterprise "Synteza" Sp. z o.o.
-
The medicinal product is used for the prevention and treatment of folic acid deficiency. It helps, among other things, in megaloblastic anemia, intestinal malabsorption, malnutrition, alcoholism, and in diseases related to chronic hemolysis. It is also used in women with an increased risk of neural tube defects in offspring.
Form: tablets
Active substance Dosage folic acid 5 mg ATC: B03BB01
Manufacturer: HASCO-LEK S.A. Pharmaceutical Production Enterprise
-
It is used for the prophylaxis and treatment of folic acid deficiency, for example in intestinal malabsorption disorders (sprue).
Form: tablets
Active substance Dosage folic acid 15 mg ATC: B03BB01
Manufacturer: HASCO-LEK S.A. Pharmaceutical Production Enterprise
-
The medicinal product is used to prevent folic acid deficiency in women during early pregnancy (which reduces the risk of neural tube defects in the child) and in women after the 12th week of pregnancy and breastfeeding women.
Form: tablets
Active substance Dosage folic acid 0.8 mg ATC: B03BB01
Manufacturer: Olimp Laboratories Ltd.
-
The medicine is used prophylactically to prevent folic acid deficiency in women before conception and during early pregnancy. This is intended to reduce the risk of neural tube defects in the child.
Form: tablets
Active substance Dosage folic acid 0.4 mg ATC: B03BB01
Manufacturer: Gedeon Richter Polska Sp. z o.o.
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Medicament
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Médicament Portugal, Ltd.
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, modified release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Medicament
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Médicament
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD
Manufacturer: Pierre Fabre Farmaka A.E.
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, film-coated, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Farmaka A.E.
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Medicament
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Médicament Portugal, Ltd.
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Médicament Portugal, Ltd.
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AA07
Manufacturer: Pierre Fabre Farmaka A.E.
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, modified release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Medicament
-
The medicinal product is used for the prevention and treatment of iron deficiency in situations of increased folic acid demand. It is intended exclusively for women during pregnancy, postpartum, and during breastfeeding.
Form: tablets, film-coated
Active substance Dosage iron 60 mg folic acid 0.4 mg ATC: B03AD05
Manufacturer: Innothera Chouzy